The non-modifiable risk factors for breast cancer development in women
DOI:
https://doi.org/10.12775/JEHS.2023.25.01.012Keywords
breast cancer, risk factors, ethnity, epidemiology of breast cancer, older age, breastAbstract
Introduction
Breasts are organs found in both male and female representatives. The main building blocks of the breast are fatty tissue and glandular tissue. As far as women are concerned, breast cancer is most commonly found in the upper outer quadrant. It is one of the most common cancers among women worldwide and is therefore an important public health issue. The latest data indicate that the problem of breast cancer currently affects more than 10% of women from all over the world. Importantly, it is the second most common cause of cancer-related death among women, after lung cancer. There are many factors that influence the prevalence rate of breast cancer. In general, they might be divided into modifiable and non-modifiable factors. In the following review, the emphasis will be put on the impact of non-modifiable factors on breast cancer risk and the strength of their impact. Factors that will be discussed include age, gender, ethnic and racial background, family history and genetic factors, pregnancy and breastfeeding.
Material and Methods
This review was based on available data collected in the PubMed and Google Scholar database, using following keywords: “Breast Cancer”, “Risk factors of Breast Cancer” and “Epidemiology of Breast Cancer”.
Conclusion
Breast cancer is one of the most common cancers in women worldwide. In recent years, we have observed an increase in the incidence of this cancer among female representatives. The development of this cancer is influenced by many factors, which can be divided into two main groups: modifiable factors and non-modifiable factors. Importantly, it is advisable to undertake new research and initiatives to better understand the etiology of this disease and the factors affecting its development.
References
Torre LA, Sauer AM, Chen MS, Kagawa-Singer M, Jemal A, Siegel RL. Cancer statistics for Asian Americans, native hawaiians, and pacific islanders, 2016: converging incidence in males and females. Cancer J Clin. 2016;66:182–202.
Aronson K, Miller A, Woolcott C, Sterns E, McCready D, Lickley L, et al. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Prev Biomarkers. 2000;9:55–63.
Stark G, Grandel S, Spilker G. Tissue suction of the male and female breast. Aesth Plast Surg. 1992;16:317–324.
Akram M, Iqbal M, Daniyal M, Khan AU. Awareness and current knowledge of breast cancer. Biol Res. 2017 Oct 2;50(1):33. doi: 10.1186/s40659-017-0140-9. PMID: 28969709; PMCID: PMC5625777.
Thomsen S, Tatman D. Physiological and pathological factors of human breast disease that can influence optical diagnosis. Ann N Y Acad Sci. 1998 Feb 9;838:171-93. doi: 10.1111/j.1749-6632.1998.tb08197.x. PMID: 9511805.
Harold Ellis, Vishy Mahadevan, Anatomy and physiology of the breast, Surgery (Oxford),Volume 31, Issue 1, 2013, Pages 11-14, ISSN 02639319, doi.org/10.1016/j.mpsur.2012.10.018.
Torre L.A., Islami F., Siegel R.L., Ward E.M., Jemal A. Global cancer in women: Burden and trends. Cancer Epidemiol. Biomarkers Prev. 2017;26:444–457. doi: 10.1158/1055-9965.EPI-16-0858.
Brayboy LM, Oulhen N, Long S, Voigt N, Raker C, Wessel GM. Multidrug resistance transporter-1 and breast cancer resistance protein protect against ovarian toxicity, and are essential in ovarian physiology. Reprod Toxicol. 2017 Apr;69:121-131. doi: 10.1016/j.reprotox.2017.02.002. Epub 2017 Feb 12. PMID: 28216407; PMCID: PMC5568689.
Hunter, C.P. (2000), Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations. Cancer, 88: 1193-1202.
Mammary gland. Vector illustration showing cross section of female breast with the names of the constituent parts isolated on white background.https://stock.adobe.com/pl/images/mammary-gland-vector-illustration-showing-cross-section-of-female-breast-with-the-names-of-the-constituent-parts-isolated-on-white-background/300610754
Ductal carcinoma of the breast. DCIS and IDC. Vector illustration showing cross section of female breast and lactiferous duct with different cancer stage. https://stock.adobe.com/pl/images/ductal-carcinoma-of-the-breast-dcis-and-idc-vector-illustration-showing-cross-section-of-female-breast-and-lactiferous-duct-with-different-cancer-stage/303574494
Zakhari S, Hoek JB. Alcohol and breast cancer: reconciling epidemiological and molecular data. Adv Exp Med Biol. 2015;815:7-39. doi: 10.1007/978-3-319-09614-8_2. PMID: 25427899.
Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA, Eheman CR, Ward EM. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014 May 1;120(9):1290-314. doi: 10.1002/cncr.28509. Epub 2013 Dec 16. PMID: 24343171; PMCID: PMC3999205.
Zavala VA, Serrano-Gomez SJ, Dutil J, Fejerman L. Genetic Epidemiology of Breast Cancer in Latin America. Genes (Basel). 2019 Feb 18;10(2):153. doi: 10.3390/genes10020153. PMID: 30781715; PMCID: PMC6410045.
Yedjou CG, Sims JN, Miele L, Noubissi F, Lowe L, Fonseca DD, Alo RA, Payton M, Tchounwou PB. Health and Racial Disparity in Breast Cancer. Adv Exp Med Biol. 2019;1152:31-49. doi: 10.1007/978-3-030-20301-6_3. PMID: 31456178; PMCID: PMC6941147.
Biancovilli P, Makszin L, Amer F, Csongor A. Celebrities and Breast Cancer: A Multidimensional Quali-Quantitative Analysis of News Stories Shared on Social Media. Int J Environ Res Public Health. 2022 Aug 5;19(15):9676. doi: 10.3390/ijerph19159676. PMID: 35955028; PMCID: PMC9368231.
Roginski M, Sifaki-Pistolla D, Stomby A, Velivasaki G, Faresjö T, Lionis C, Faresjö Å. Paradoxes of breast cancer incidence and mortality in two corners of Europe. BMC Cancer. 2022 Nov 2;22(1):1123. doi: 10.1186/s12885-022-10243-w. PMID: 36319987; PMCID: PMC9628067.
Stachs A, Stubert J, Reimer T, Hartmann S. Benign Breast Disease in Women. Dtsch Arztebl Int. 2019 Aug 9;116(33-34):565-574. doi: 10.3238/arztebl.2019.0565. PMID: 31554551; PMCID: PMC6794703.
Shoemaker ML, White MC, Wu M, Weir HK, Romieu I. Differences in breast cancer incidence among young women aged 20-49 years by stage and tumor characteristics, age, race, and ethnicity, 2004-2013. Breast Cancer Res Treat. 2018 Jun;169(3):595-606. doi: 10.1007/s10549-018-4699-9. Epub 2018 Feb 14. PMID: 29445940; PMCID: PMC5955792.
Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022 Feb 1;95(1130):20211033. doi: 10.1259/bjr.20211033. Epub 2021 Dec 14. PMID: 34905391; PMCID: PMC8822551.
Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers (Basel). 2021 Aug 25;13(17):4287. doi: 10.3390/cancers13174287. PMID: 34503097; PMCID: PMC8428369.
Douglas Hanahan, Robert A Weinberg, The Hallmarks of Cancer, Cell, Volume 100, Issue 1, 2000, Pages 57-70, ISSN 0092-8674, doi.org/10.1016/S0092-8674(00)81683-9.
Thakur, Purnima, et al. "Breast cancer risk factor evaluation in a Western Himalayan state: A case–control study and comparison with the Western World." South Asian journal of cancer 6.03 (2017): 106-109.
McGuire, A.; Brown, J.A.L.; Malone, C.; McLaughlin, R.; Kerin, M.J. Effects of Age on the Detection and Management of Breast Cancer. Cancers 2015, 7, 908-929. doi.org/10.3390/cancers7020815
DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011 Nov-Dec;61(6):409-18. doi: 10.3322/caac.20134. Epub 2011 Oct 3. PMID: 21969133.
Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer. 1997 Oct 1;80(7):1273-83. PMID: 9317180.
Chen HL, Zhou MQ, Tian W, Meng KX, He HF. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database. PLoS One. 2016 Oct 31;11(10):e0165409. doi: 10.1371/journal.pone.0165409. PMID: 27798652; PMCID: PMC5087840.
Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press). 2019 Apr 10;11:151-164. doi: 10.2147/BCTT.S176070. PMID: 31040712; PMCID: PMC6462164.
Johnson RH, Anders CK, Litton JK, Ruddy KJ, Bleyer A. Breast cancer in adolescents and young adults. Pediatr Blood Cancer. 2018 Dec;65(12):e27397. doi: 10.1002/pbc.27397. Epub 2018 Aug 28. PMID: 30156052; PMCID: PMC6192832.
Gnerlich JL, Deshpande AD, Jeffe DB, Seelam S, Kimbuende E, Margenthaler JA. Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration. Ann Surg Oncol. 2011 Jul;18(7):1837-44. doi: 10.1245/s10434-010-1468-3. Epub 2010 Dec 14. PMID: 21484520; PMCID: PMC3277785.
Stang A, Thomssen C. Decline in breast cancer incidence in the United States: what about male breast cancer? Breast Cancer Res Treat. 2008 Dec;112(3):595-6. doi: 10.1007/s10549-007-9882-3. Epub 2008 Jan 5. PMID: 18176840
Speirs V, Shaaban AM. The rising incidence of male breast cancer. Breast Cancer Res Treat. 2009 May;115(2):429-30. doi: 10.1007/s10549-008-0053-y. Epub 2008 May 14. PMID: 18478326.
Key, T. J., et al. "Endogenous Hormones and Breast Cancer Collaborative Group. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies." Lancet Oncol 14.10 (2013): 1009-1019.
Gucalp, Ayca, et al. "Male breast cancer: a disease distinct from female breast cancer." Breast cancer research and treatment 173 (2019): 37-48.
Giordano, Sharon H. "Breast cancer in men." New England Journal of Medicine 378.24 (2018): 2311-2320.
Bernstein, L. Epidemiology of Endocrine-Related Risk Factors for Breast Cancer. J. Mammary Gland. Biol. Neoplasia 2002, 7, 3–15.
van Driel C, Oosterwijk J, Meijers-Heijboer E, Van Asperen C, Zeijlmans van Emmichoven I, de Vries J et al (2016) Psychological factors associated with the intention to choose for riskreducing mastectomy in family cancer clinic attendees. The Breast 30:66–72
Yedjou CG, Sims JN, Miele L, Noubissi F, Lowe L, Fonseca DD, Alo RA, Payton M, Tchounwou PB. Health and Racial Disparity in Breast Cancer. Adv Exp Med Biol. 2019;1152:31-49. doi: 10.1007/978-3-030-20301-6_3. PMID: 31456178; PMCID: PMC6941147.
Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001; 358:1389–99.
Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015
Bogdanova N, Helbig S, Dörk T. Hereditary breast cancer: ever more pieces to the polygenic puzzle. Hered Cancer Clin Pract. 2013 Sep 11;11(1):12. doi: 10.1186/1897-4287-11-12. PMID: 24025454; PMCID: PMC3851033.
Narod SA, Salmena L. BRCA1 and BRCA2 mutations and breast cancer. Discov Med. 2011 Nov;12(66):445-53. PMID: 22127115.
Migliavacca Zucchetti, B., Peccatori, F.A., Codacci-Pisanelli, G. (2020). Pregnancy and Lactation: Risk or Protective Factors for Breast Cancer?. In: Alipour, S., Omranipour, R. (eds) Diseases of the Breast during Pregnancy and Lactation. Advances in Experimental Medicine and Biology, vol 1252. Springer, Cham. doi.org/10.1007/978-3-030-41596-9_27.
Kotsopoulos, J., Lubinski, J., Salmena, L. et al. Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 14, R42 (2012). Doi.org/10.1186/bcr3138.
Slepicka PF, Cyrill SL, Dos Santos CO. Pregnancy and Breast Cancer: Pathways to Understand Risk and Prevention. Trends Mol Med. 2019 Oct;25(10):866-881. doi: 10.1016/j.molmed.2019.06.003. Epub 2019 Aug 2. PMID: 31383623.
Sun, Xuezheng, et al. "Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic SubtypeBreast Cancer Prognosis and Parity." Cancer Epidemiology, Biomarkers & Prevention 25.1 (2016): 60-67.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Mikołaj Dadziak, Paweł Olko, Magdalena Alicja Zapała, Adrian Hunek, Karolina Chmielarz, Joanna Wiśniewska-Skomra, Kinga Tylutka, Anna Hapon, Karolina Kaziród
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 404
Number of citations: 0